Gentium Receives Marketing Authorization for Defitelio

Gentium S.p.A. has reported that the European Commission has granted a marketing authorization for Defitelio for the treatment of severe hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem-cell transplantation therapy.

http://www.pharmtech.com/pharmtech/Industry+News/Gentium-Receives-Marketing-Authorization-for-Defit/ArticleStandard/Article/detail/826646?ref=25